Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Cross-sectional Observational Study to Describe Treatment Management of Patients With Major Depressive Disorder (MDD) and Inadequate Response to Antidepressants in Greece

NCT01397903 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01397903
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01397903 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Cross-sectional Observational Study to Describe Treatment Management of Patients With Major Depressive Disorder (MDD) and Inadequate Response to Antidepressants in Greece
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
September 30, 2011
Completion date
March 31, 2012
Enrollment
545 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder